![Rebecca Ashfield](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Rebecca Ashfield is the Chief Scientific Officer and founder of Ducentis BioTherapeutics Ltd., which is founded in 2014.
Actieve functies van Rebecca Ashfield
Bedrijven | Functie | Begin |
---|---|---|
Ducentis BioTherapeutics Ltd.
![]() Ducentis BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Ducentis Biotherapeutics Ltd. develops novel therapies for inflammation and autoimmune disease. The company was founded by Rebecca Ashfield, David Blackbourn and Philip Huxley in March 2015 and is headquartered in Witney, the United Kingdom. | Oprichter | 12-11-2014 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Ducentis BioTherapeutics Ltd.
![]() Ducentis BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Ducentis Biotherapeutics Ltd. develops novel therapies for inflammation and autoimmune disease. The company was founded by Rebecca Ashfield, David Blackbourn and Philip Huxley in March 2015 and is headquartered in Witney, the United Kingdom. | Health Technology |